Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it has completed harvesting and drying its first two lots of cannabis at its Hamilton, Ontario facility; a process required by Health Canada prior to requesting a sales license. The Company will apply for a license to sell dried cannabis after it …
Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it has completed harvesting and drying its first two lots of cannabis at its Hamilton, Ontario facility; a process required by Health Canada prior to requesting a sales license. The Company will apply for a license to sell dried cannabis after it has received confirmation from a third-party laboratory that quality assurance testing results are compliant with the Access to Cannabis for Medical Purposes Regulations.
“We are extremely pleased with everything having gone according to what we expected. Furthermore, we have developed quite a bit of knowledge with respect to the strains we are cultivating, and are continually fine tuning our growing practices to optimize these strains for large scale commercial production,” commented Beleave CEO, Roger Ferreira. “Our facility is now in full production, with plants at each stage of the growth cycle. We anticipate a quick turnaround time between crops moving forward.”
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is located near Hamilton, Ontario.
For further information please contact:
This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. These risks and uncertainties include, but are not limited to, the Company’s ability to satisfy the conditions associated with its cultivation licence, the Company’s ability to obtain a sales licence and the related timing considerations, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.